Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Futamura

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
International Immunopharmacology|January 3, 2021
Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort studyTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
Internal Medicine (Tokyo, Japan)|October 26, 2022
Galactose-deficient IgA1 Is Involved in IgA Deposition in Renal Grafts Biopsied One Hour after Kidney TransplantationYuki Kuroyanagi, Asami Takeda, Hiroshi Kinashi, et al.
BMC Nephrology|June 16, 2022
Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemiaManabu Okada, Yoshihiro Tominaga, Tetsuhiko Sato, et al.
Kidney International Reports|December 13, 2021
Adult Living-Donor Kidney Transplantation, Donor Age, and Donor-Recipient AgeTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
International Immunopharmacology|August 5, 2016
5-year follow-up of a randomized clinical study comparing everolimus plus reduced-dose cyclosporine with mycophenolate mofetil plus standard-dose cyclosporine in de novo kidney transplantation: Retrospective single center assessmentTakahisa Hiramitsu, Manabu Okada, Kenta Futamura, et al.
Surgery Today|March 28, 2024
Lung cancer after kidney transplantation: a 50-year experience at a single institutionHiroki Watanabe, Yuka Kadomatsu, Shuhei Hakiri, et al.
Frontiers in Medicine|September 18, 2023
Prediction models for the recipients' ideal perioperative estimated glomerular filtration rates for predicting graft survival after adult living-donor kidney transplantationTakahisa Hiramitsu, Yuki Hasegawa, Kenta Futamura, et al.
Clinical and Experimental Nephrology|July 4, 2025
Post-transplantation management of hyperparathyroidism and its association with kidney graft survival and fibrosisManabu Okada, Tetsuhiko Sato, Tomoki Himeno, et al.
Clinical and Experimental Nephrology|November 1, 2022
Short-term outcomes of second kidney transplantation compared with those of first transplantation in Japanese patients: a single-center, retrospective, observational studyHiroki Fukuhara, Takaaki Nawano, Akiko Kanda, et al.
Journal of Bone and Mineral Metabolism|August 24, 2022
Risk factors for subchondral insufficiency fracture of the femoral head in renal transplant patientsYoshitoshi Higuchi, Toshihide Tomosugi, Kenta Futamura, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
International Immunopharmacology|January 3, 2021
Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort studyTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
Internal Medicine (Tokyo, Japan)|October 26, 2022
Galactose-deficient IgA1 Is Involved in IgA Deposition in Renal Grafts Biopsied One Hour after Kidney TransplantationYuki Kuroyanagi, Asami Takeda, Hiroshi Kinashi, et al.
BMC Nephrology|June 16, 2022
Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemiaManabu Okada, Yoshihiro Tominaga, Tetsuhiko Sato, et al.
Kidney International Reports|December 13, 2021
Adult Living-Donor Kidney Transplantation, Donor Age, and Donor-Recipient AgeTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
International Immunopharmacology|August 5, 2016
5-year follow-up of a randomized clinical study comparing everolimus plus reduced-dose cyclosporine with mycophenolate mofetil plus standard-dose cyclosporine in de novo kidney transplantation: Retrospective single center assessmentTakahisa Hiramitsu, Manabu Okada, Kenta Futamura, et al.
Surgery Today|March 28, 2024
Lung cancer after kidney transplantation: a 50-year experience at a single institutionHiroki Watanabe, Yuka Kadomatsu, Shuhei Hakiri, et al.
Frontiers in Medicine|September 18, 2023
Prediction models for the recipients' ideal perioperative estimated glomerular filtration rates for predicting graft survival after adult living-donor kidney transplantationTakahisa Hiramitsu, Yuki Hasegawa, Kenta Futamura, et al.
Clinical and Experimental Nephrology|July 4, 2025
Post-transplantation management of hyperparathyroidism and its association with kidney graft survival and fibrosisManabu Okada, Tetsuhiko Sato, Tomoki Himeno, et al.
Clinical and Experimental Nephrology|November 1, 2022
Short-term outcomes of second kidney transplantation compared with those of first transplantation in Japanese patients: a single-center, retrospective, observational studyHiroki Fukuhara, Takaaki Nawano, Akiko Kanda, et al.
Journal of Bone and Mineral Metabolism|August 24, 2022
Risk factors for subchondral insufficiency fracture of the femoral head in renal transplant patientsYoshitoshi Higuchi, Toshihide Tomosugi, Kenta Futamura, et al.
Pageof 7